Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Did lack of R&D success catch up with Merck’s Peter Kim?

This article was originally published in Scrip

Executive Summary

In December 2012, Scrip analyzed the performance of four R&D chiefs. Peter Kim came plumb last, and now he is ex-Merck. Roger Perlmutter, his replacement at Merck, didn’t do that well either.

You may also be interested in...

JP MORGAN 2013: What kind of focus is the future?

You hear a lot about focus in the crowded meeting rooms of the 31st annual JP Morgan Healthcare Conference in San Francisco this week. It even takes focus to navigate the jammed hallways. Focus. Focus. And more focus.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts